NO995622L - Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner - Google Patents

Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner

Info

Publication number
NO995622L
NO995622L NO995622A NO995622A NO995622L NO 995622 L NO995622 L NO 995622L NO 995622 A NO995622 A NO 995622A NO 995622 A NO995622 A NO 995622A NO 995622 L NO995622 L NO 995622L
Authority
NO
Norway
Prior art keywords
treatment
viral infections
carbocyclic nucleoside
hemisulfate
nucleoside hemisulfate
Prior art date
Application number
NO995622A
Other languages
English (en)
Other versions
NO995622D0 (no
NO324731B1 (no
Inventor
Alastair BRODIE
Martin Francis Jones
John Frederick Seager
Christopher John Wallis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10812407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995622(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO995622D0 publication Critical patent/NO995622D0/no
Publication of NO995622L publication Critical patent/NO995622L/no
Publication of NO324731B1 publication Critical patent/NO324731B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
NO19995622A 1997-05-17 1999-11-16 Karbocyklisk hemisulfat, anvendelse og fremstilling derav, samt farmasoytisk formulering og dikarboksylatsalt, gutarsalt og monosulfat, benzoat eller salicylatsalt NO324731B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt
PCT/EP1998/002835 WO1998052949A1 (en) 1997-05-17 1998-05-14 Carbocyclic nucleoside hemisulfate and its use in treating viral infections

Publications (3)

Publication Number Publication Date
NO995622D0 NO995622D0 (no) 1999-11-16
NO995622L true NO995622L (no) 2000-01-14
NO324731B1 NO324731B1 (no) 2007-12-03

Family

ID=10812407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995622A NO324731B1 (no) 1997-05-17 1999-11-16 Karbocyklisk hemisulfat, anvendelse og fremstilling derav, samt farmasoytisk formulering og dikarboksylatsalt, gutarsalt og monosulfat, benzoat eller salicylatsalt

Country Status (51)

Country Link
US (1) US6294540B1 (no)
EP (1) EP0983271B1 (no)
JP (2) JP3150711B2 (no)
KR (1) KR100521292B1 (no)
CN (2) CN1150194C (no)
AP (1) AP2009A (no)
AR (2) AR015668A1 (no)
AT (1) ATE259811T1 (no)
AU (1) AU739953B2 (no)
BG (1) BG64390B1 (no)
BR (1) BRPI9809126B8 (no)
CA (1) CA2289753C (no)
CO (1) CO4940435A1 (no)
DE (1) DE69821758T2 (no)
DK (1) DK0983271T3 (no)
DZ (1) DZ2493A1 (no)
EA (1) EA001809B1 (no)
EE (1) EE03924B1 (no)
EG (1) EG23836A (no)
ES (1) ES2214712T3 (no)
GB (3) GB9709945D0 (no)
GE (1) GEP20022680B (no)
HK (1) HK1024236A1 (no)
HN (1) HN1998000071A (no)
HR (1) HRP980265B1 (no)
HU (1) HU226563B1 (no)
ID (1) ID24910A (no)
IL (2) IL132793A0 (no)
IS (1) IS2207B (no)
JO (1) JO2032B1 (no)
MA (1) MA26498A1 (no)
MY (1) MY120151A (no)
NO (1) NO324731B1 (no)
NZ (2) NZ510622A (no)
OA (1) OA11304A (no)
PA (1) PA8451301A1 (no)
PE (1) PE78799A1 (no)
PL (1) PL189527B1 (no)
PT (1) PT983271E (no)
RS (1) RS49655B (no)
SA (1) SA98190179B1 (no)
SI (1) SI0983271T1 (no)
SK (1) SK285159B6 (no)
SV (1) SV1998000057A (no)
TN (1) TNSN98065A1 (no)
TR (1) TR199902810T2 (no)
TW (1) TW480259B (no)
UA (1) UA56231C2 (no)
UY (1) UY25004A1 (no)
WO (1) WO1998052949A1 (no)
ZA (2) ZA984085B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (en) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
AU2007301934A1 (en) * 2006-09-28 2008-04-03 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
EA025176B1 (ru) 2010-01-27 2016-11-30 Вайв Хелткер Компани Комбинация для лечения вич-инфекции
ES2729824T3 (es) 2011-04-08 2019-11-06 Laurus Labs Ltd Formas sólidas de compuestos antirretrovirales, procedimiento para la preparación y composición farmacéutica de los mismos
JP6391561B2 (ja) 2013-02-27 2018-09-19 国立大学法人京都大学 がんの予防または治療用医薬組成物
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
PE87398A1 (es) * 1996-06-25 1999-01-15 Glaxo Group Ltd Combinaciones antivirales

Also Published As

Publication number Publication date
CA2289753A1 (en) 1998-11-26
PT983271E (pt) 2004-07-30
CN1263529A (zh) 2000-08-16
NO995622D0 (no) 1999-11-16
CN1515572A (zh) 2004-07-28
YU59599A (no) 2002-08-12
EA001809B1 (ru) 2001-08-27
SA98190179B1 (ar) 2006-08-15
ZA984085B (en) 2000-01-26
AR059120A2 (es) 2008-03-12
CO4940435A1 (es) 2000-07-24
GB2348202B (en) 2001-08-08
ATE259811T1 (de) 2004-03-15
HRP980265B1 (en) 2004-10-31
UY25004A1 (es) 2000-10-31
JP3150711B2 (ja) 2001-03-26
DK0983271T3 (da) 2004-05-10
IS2207B (is) 2007-02-15
SK156199A3 (en) 2000-07-11
EE9900537A (et) 2000-06-15
US6294540B1 (en) 2001-09-25
JP2000327679A (ja) 2000-11-28
NO324731B1 (no) 2007-12-03
UA56231C2 (uk) 2003-05-15
OA11304A (en) 2003-10-22
KR20010012623A (ko) 2001-02-26
PL189527B1 (pl) 2005-08-31
GB9709945D0 (en) 1997-07-09
AU739953B2 (en) 2001-10-25
PL336888A1 (en) 2000-07-17
GB2348202A (en) 2000-09-27
GB9926839D0 (en) 2000-01-12
TR199902810T2 (xx) 2000-02-21
KR100521292B1 (ko) 2005-10-17
EP0983271A1 (en) 2000-03-08
EE03924B1 (et) 2002-12-16
GB0010222D0 (en) 2000-06-14
HU226563B1 (en) 2009-04-28
EA199900944A1 (ru) 2000-06-26
JO2032B1 (en) 1999-05-15
AU7765598A (en) 1998-12-11
IS5246A (is) 1999-11-11
GEP20022680B (en) 2002-04-25
CN100408580C (zh) 2008-08-06
DE69821758T2 (de) 2005-01-13
BG64390B1 (bg) 2004-12-30
EP0983271B1 (en) 2004-02-18
IL132793A0 (en) 2001-03-19
GB2340491B (en) 2000-10-18
JP2000514096A (ja) 2000-10-24
HUP0002754A3 (en) 2003-01-28
AP2009A (en) 2009-06-26
PA8451301A1 (es) 2000-05-24
MY120151A (en) 2005-09-30
HK1024236A1 (en) 2000-10-05
PE78799A1 (es) 1999-08-31
HN1998000071A (es) 1999-03-19
ID24910A (id) 2000-08-31
GB2340491A (en) 2000-02-23
TW480259B (en) 2002-03-21
AP9901688A0 (en) 1999-12-31
DE69821758D1 (de) 2004-03-25
AR015668A1 (es) 2001-05-16
IL132793A (en) 2006-10-31
SI0983271T1 (en) 2004-06-30
WO1998052949A1 (en) 1998-11-26
TNSN98065A1 (fr) 2005-03-15
BG103959A (en) 2000-12-29
SK285159B6 (sk) 2006-07-07
BRPI9809126B8 (pt) 2021-07-06
EG23836A (en) 2007-10-02
ES2214712T3 (es) 2004-09-16
RS49655B (sr) 2007-09-21
MA26498A1 (fr) 2004-12-20
ZA984083B (en) 1999-11-15
HRP980265A2 (en) 1999-02-28
BR9809126A (pt) 2000-08-01
DZ2493A1 (fr) 2004-06-20
BRPI9809126B1 (pt) 2018-02-06
HUP0002754A2 (hu) 2001-06-28
NZ500865A (en) 2001-04-27
CA2289753C (en) 2007-01-23
CN1150194C (zh) 2004-05-19
SV1998000057A (es) 1999-03-02
NZ510622A (en) 2002-04-26

Similar Documents

Publication Publication Date Title
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20006178L (no) Anvendelse av PEG-IFN-<alfa> og ribavirin for behandling av kronisk hepatitt C
DK0821690T3 (da) Nukleotidanaloger til behandling af virusinfektioner
DE69930647D1 (de) Struktur-analoga von amin-basen und nucleosiden
NO995622D0 (no) Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
NO940810D0 (no) Behandling av virusinfeksjoner
NO20022816D0 (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
KR960007615A (ko) 치료 및 진단용 핵산-결합 올리고머
NO983402D0 (no) Nukeosidanaloger i kombinasjonsterapi av herpes simplex infeksjoner
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
DK0799039T3 (da) Anvendelse af antivirale aminopurin-præparater til behandling og profylakse af latente herpesvirus infektioner
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
DK1122245T3 (da) 2-Aminobenzoxazinoner til behandling af virale infektioner
SE9902548D0 (sv) Twin-panel and multiple-panel apparatus and the ways of using them
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
IT241783Y1 (it) Orecchino di tipo perfezionato
NO920258L (no) Adenosinderivater, fremgangsmaate for deres fremstilling og anvendelse derav

Legal Events

Date Code Title Description
MK1K Patent expired